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that can share or not share epidemio-
logic elements.
Molecular identification of R. 
rickettsii in A. cajennense ticks was 
recorded only in the Paraíba do Sul 
River basin of southeastern Brazil 
(8), as confirmed in our study. This 
eco-epidemiologic aspect, its great 
anthropophily, and its presence in all 
municipalities surveyed, with absolute 
frequency greater than other species, 
demonstrates the possible effect of this 
tick on epidemic cycle development 
for the analyzed region, which does 
not seem to occur in other regions.
R. rickettsii infection of A. du-
bitatum ticks in the 1 focus analyzed 
might indicate its relevance in specific 
epidemiologic scenarios. We detected 
highly similar sequences of different 
species of Rickettsia (LIC2937A) in 
the same A. dubitatum tick specimen 
(Figure). Other studies have recorded 
multiple Rickettsia infections in 1 tick 
specimen (9,10).
Our finding of C. felis fleas in 6 of 
the 7 outbreaks investigated highlights 
the possible role of this flea in maintain-
ing Rickettsia in Rio de Janeiro state. C. 
felis and C. canis fleas infected with R. 
rickettsii seem to confirm this potential. 
Nevertheless, the real epidemiologic 
value of this report in the BSF cycle 
deserves to be further investigated.
Our results indicate that dogs and 
horses are the primary vertebrates in 
the Rickettsia enzootic cycle in the 
investigated focus, and, considering 
their common presence in human en-
vironments, they must be important in 
maintaining possible rickettsial vec-
tors to humans. These results contrib-
ute to the mapping of BSF-endemic 
areas and to the understanding of the 
circulation and epidemiology of Rick-
ettsia sp. in an area with one of the 
highest fatal concentrations of BSF.
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Atypical  
Streptococcus suis 
in Man,  
Argentina, 2013
To the Editor: Streptococ-
cus suis is a major swine pathogen 
and an emerging zoonotic agent that 
causes mainly meningitis and septic 
shock (1,2). Among the 35 described 
1These	 authors	 contributed	 equally	 to	 this	
article.
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serotypes classified by differences in 
capsular antigens, serotype 2 is the 
most frequently isolated from humans 
worldwide, and serotype 14 cases are 
also increasing in some countries (1). 
In Southeast Asia, this pathogen af-
fects not only workers in close contact 
with pig/pork by-products but also the 
general population, probably because 
of the widespread presence of back-
yard types of pig production, open 
meat markets, and some special dishes 
prepared with raw meat or blood (3). 
We report a case of peritonitis caused 
by an atypical S. suis serotype 21 
strain in a patient in Argentina.
A 62-year-old man from Santa 
Fe Province in Argentina, who had a 
history of tobacco and alcohol abuse, 
was hospitalized in 2013 as an emer-
gency patient with symptoms of acute 
abdominal distress. Ten days before 
admission, abdominal distention, ac-
companied by intense upper abdomi-
nal pain, developed in the patient. The 
patient’s family reported that he had 
been having gastrointestinal bleeding 
4 days before admission, and he was 
suspected of having diabetes.
At admission, a physical examina-
tion indicated jaundice, hepatospleno-
megaly, and ascites. A neurologic 
examination indicated that the patient 
was conscious, but disoriented, and 
that his vital signs were stable. The 
patient had a temperature of 38.9°C, a 
pulse rate of 130 beats/min, and blood 
pressure of 110/70 mm Hg. Other lab-
oratory results were a leukocyte count 
of 2,900 cells/μL (70% neutrophils), a 
platelet count of 94,000/μL, a serum 
hemoglobin concentration of 13.20 g/
dL, a glucose concentration of 195 mg/
dL, a blood urea nitrogen level of 42 
mg/dL, a creatinine level of 0.96 mg/
dL; a serum bilirubin level of 3.01 mg/
dL, an alanine aminotransferase level 
of 35 U/L, an aspartate aminotransfer-
ase level of 70 U/, a serum albumin 
level of 2.66 g/dL, and an increase in 
prothrombin time to 22 s.
Spontaneous bacterial peritonitis 
was suspected. Abdominal paracentesis 
was performed and produced a turbid 
milky fluid, with a protein level of 
1600 mg/dL; 1,340 cells/µL (90% neu-
trophils), a lactate dehydrogenase level 
of 221 U/L, and an amylase level of 
34 U/L. Samples of blood and ascitic 
fluid were inoculated into aerobic and 
anaerobic blood culture bottles. Gram 
staining was performed and no organ-
isms were observed.
Treatment with intravenous cef-
triaxone (2g/day) was started after a 
diagnosis of spontaneous bacterial 
peritonitis associated with liver cir-
rhosis was made. After 48 h of incuba-
tion, cultures of blood and ascetic fluid 
were plated onto sheep blood agar and 
chocolate agar and incubated at 35°C 
in an atmosphere of 5% CO2. After 
24 h of incubation, cultures showed 
growth of α-hemolytic streptococci.
An API Strep Test (bioMérieux, 
Marcy l’Etoile, France) identified the 
isolate as S. pneumoniae (probability 
58.7%) or S. suis (probability 20.7%). 
However, these 2 probability values 
are unacceptable identification con-
fidence levels. Therefore, the species 
and serotype were identified by se-
quence analysis of a 16S rRNA gene 
and a coagglutination test as described 
(4,5). The isolate was identified as 
S. suis serotype 21.
The infection was considered re-
solved when all signs and symptoms 
of infection disappeared, a polymor-
phonuclear cell count in ascitic fluid 
decreased to <250 cells/mL, and ascitic 
fluid cultures were negative for bacteria. 
Antimicrobial drug therapy was given 
for 48 h after resolution of the infection. 
The patient denied any recent occupa-
tional or occasional contact with swine 
or other animals, and he had no history 
of eating raw or undercooked pork.
A biochemically and antigeni-
cally atypical strain was isolated 
from the patient with peritonitis. A 
reference strain of serotype 21 and 
most other strains of this serotype 
had been isolated from tonsils of 
healthy pigs (6). However, 16 strains 
had also been isolated from sick pigs 
during 2008–2011 in Canada (7). 
These findings indicate that this se-
rotype is potentially virulent. Most 
strains, including the strain from 
the patient reported, are usually not 
identified as S. suis by rapid multitest 
identification systems (6).
There are only 2 reports of S. suis 
being isolated from humans in Latin 
America; these reports were also from 
Argentina (8,9). Because swine pro-
duction in Argentina is a smaller in-
dustry than in other Latin American 
countries, the higher rate of S. suis 
isolation rate is probably the conse-
quence of good surveillance systems 
and awareness of the pathogen by lo-
cal diagnostic laboratories.
The patient did not have any 
contact with swine, pork-derived 
products, or raw/undercooked beef. 
A patient infected with S. suis might 
be unaware or have no recollection of 
exposure to animals. Latent infection, 
with reactivation many years later, 
has been reported (10). S. suis might 
become an opportunistic pathogen in 
persons who are stressed or immuno-
deficient. This pathogen has also been 
increasingly isolated from mammals 
other than pigs and from the environ-
ment. The patient in this study had 
a history of alcohol consumption, 
which is a reported risk factor for 
this infection (3).
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Cutaneous  
Leishmaniasis 
Caused by  
Leishmania killicki, 
Algeria
To the Editor: Cutaneous leish-
maniasis (CL) is a widespread and 
resurging vector-borne disease caused 
by a protozoan parasite belonging to 
genus Leishmania (1). After Afghani-
stan, Algeria is the second largest fo-
cus of CL in the world. Although CL 
is a serious public health problem in 
Algeria, few data are available from 
this country. 
During 2004–2008, an average of 
≈44,050 CL cases were reported per 
year, and the estimated annual inci-
dence ranged from 123,300 to 202,600 
cases. Two main forms of CL have 
been described for more than a cen-
tury in Algeria, the zoonotic, caused 
by L. major and the sporadic, caused 
by L. infantum. Since 2004, 11 strains 
belonging to the L. tropica complex, 
including L. killicki (2), were identi-
fied in 1 focus in the northern part 
of the Sahara (3) and in 2 foci in the 
northeastern Algeria (4,5). We report 
here a recent outbreak of CL, includ-
ing infection with L. killicki strains, in 
the Tipaza area of northern Algeria.
Patients who sought treatment at 
Hajout hospital in Hajout, Algeria (a 
community of ≈51,000 persons), from 
January 2010 through April 2013 with 
cutaneous lesions consistent with 
leishmaniasis, underwent clinical ex-
amination. For each patient (146 to-
tal), we collected epidemiologic data 
(geographic origin, traveling history, 
especially to other leishmaniasis-en-
demic areas) and clinical data (number 
and size of lesions and clinical forms). 
Informed consent was obtained from 
all patients or their legal guardians. 
A particular characteristic of the in-
fections was the unusual duration of 
some episodes, one of which persisted 
for >4 years, which is compatible with 
leishmaniasis recidivans (6). 
Microbiological data were ob-
tained as follows. Tissue samples, 
obtained by scraping the internal 
border of skin lesions from patients, 
were smeared onto a glass slide, fixed 
with methanol, stained with Giemsa, 
and examined by microscopy. Slides 
showing Leishmania amastigote 
forms were then processed further for 
molecular analyses. The immersion 
oil used to examine each slide was 
wiped off the smear with tissue paper, 
and then the dry smear was scraped 
from its slide by using a sterile scalpel. 
DNA extraction from smear scrapings 
was performed with the NucleoSpin 
Tissue kit (Macherey-Nagel, Düren, 
Germany). Species identification was 
performed by amplifying the topoi-
somerase II gene, followed by DNA 
sequencing (7).
In total, 60 patients exhibited 
Leishmania-positive cutaneous lesions 
as determined by microscopy. The 
topoisomerase II gene was success-
fully amplified and sequenced from 
samples from 38 patients. Leishmania 
species were identified by comparing 
sequences with those of the reference 
strains L. infantum MHOM/FR/78/
LEM75, L. killicki MHOM/TN/80/
LEM163, and L. major MHOM/
MA/81/LEM265 (7). L. infantum was 
identified in 36 cases and L. killicki in 
2 cases (Figure). No L. major isolates 
were found in this series.
The low proportion of L. killicki 
strains was similar to that found re-
cently in the Annaba focus in north-
eastern Algeria (5). However, the ob-
servation of a new focus of CL and L. 
killicki as etiologic agent may indicate 
a modification of the epidemiology of 
CL in Algeria. This focus, located far 
from other previously described areas 
where the L. tropica complex is en-
demic, may reflect geographic spread 
of this complex in Algeria. 
The results of this study can 
be placed in a larger framework as 
well. Since 2004, strains in the L. 
tropica complex have been increas-
ingly reported as responsible for CL 
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